Press Release: Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity(TM) Urinary Management Portfolio

Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent urinary incontinence MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity(TM) portfolio, including the Surity(TM) Urinary Management System and Surity(TM) Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S. The Surity(TM) portfolio provides non-invasive management solutions for individuals living with urinary incontinence and is designed to make everyday urine management more comfortable, discreet and reliable. Coding verification under Healthcare Common Procedure Coding System (HCPCS) codes A6590 for the Surity(TM) Female and Male External Catheters and E2001 for the Surity(TM) Urinary Management System supports reimbursement access for beneficiaries who meet applicable coverage criteria..